Camp4 Therapeutics CORP (CAMP) — 10-Q Filings
All 10-Q filings from Camp4 Therapeutics CORP. Browse 4 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (4)
-
Camp4's Q3 Loss Widens to $15.1M Despite New Collaboration Revenue
— Nov 6, 2025 Risk: high
Camp4 Therapeutics Corp reported a net loss of $15.099 million for the three months ended September 30, 2025, an increase from $13.484 million in the same perio -
Camp4's Losses Persist Amid Rising R&D, Cash Drains
— Aug 14, 2025 Risk: high
Camp4 Therapeutics Corp (CAMP) reported a net loss of $12.587 million for the three months ended June 30, 2025, a slight increase from $12.576 million in the sa -
Camp4 Therapeutics Files Q1 2025 10-Q
— May 13, 2025 Risk: medium
Camp4 Therapeutics Corp filed a 10-Q for the period ending March 31, 2025. The company, located at One Kendall Square in Cambridge, MA, is in the pharmaceutical -
Camp4 Therapeutics Q3 2024 Update
— Nov 21, 2024 Risk: medium
Camp4 Therapeutics Corp. reported its financial results for the period ending September 30, 2024. The company's financial statements indicate a fiscal year end
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX